About Us

WHAT IF...

the right blend of people plus pharmaceutical innovation could provide solutions to redefine today’s medicines? At Innocoll, our focus on engineering collagen-based products and medicines—for better patient outcomes—begins with our people.


Innocoll is dedicated to making better happen — finding solutions to help patients reduce pain associated with surgeries and to treat limb-threatening infections.

Our proprietary, biocompatible, and biodegradable collagen-based products are engineered for targeted use. Applied locally to wound and/or surgery sites, they are designed to provide a range of treatment benefits.

Our late-stage product pipeline is focused on addressing a number of significant unmet medical needs: INL-001, bioresorbable bupivacaine HCI collagen-matrix implants (Phase III completed), in development for postsurgical analgesia; INL-002, a gentamicin collagen-matrix patch, in development for the treatment of diabetic foot infections (Phase III completed); and INL-003, a bioresorbable collagen film surgical adhesion barrier (approved ex-US), in development for the prevention of postsurgical adhesions.

Our currently approved products include: COLLAGUARD® (ex-US), COLLATAMP® G, SEPTOCOLL® E, REGENEPRO®, COLLACARE®, COLLEXA®, and ZORPREVA®, some of which are sold globally through strategic partnerships. All of our collagen products—from extraction/purification of Type 1 collagen through final delivery— are manufactured at our certified, integrated plant in Saal, Germany.

Our Pipeline Products

“As we look toward the future, the success of Innocoll is predicated on continuing to deliver inspired innovation through targeted solutions that help make today’s medicines work better. By designing innovative site-specific treatment options, we’re bringing that vision to light: improving patient lives and enhancing outcomes—and fulfilling our promise of making better happen.”

– Anthony Zook, CEO, Innocoll

OUR SENIOR MANAGEMENT

Leading Innocoll innovations is a team of seasoned professionals with a proven track record of success throughout all areas of product development and growth, from research and development through commercialization.

Learn More
Board of Directors

Our board is comprised of some of the most talented, intelligent business minds in the industry. Together, they help ensure that our vision stays true and that we continue to execute against our plans for continued growth.

Learn More

Our Manufacturing


Since 1985, Innocoll has ensured consistency and quality of all of its products by engineering and manufacturing within its own facility in Saal, Germany.

We recently fully integrated our manufacturing capabilities at our newly constructed state-of-the-art facility, beginning with the extraction and purification of the Type 1 collagen (from bovine and equine Achilles tendons), which is further processed using one of our proprietary technologies to produce final finished products in the forms of matrices, films, powders, liquids, and gels. Our facility in Germany is cGMPs compliant. The facility is also ISO 13485 certified.

Syntacoll GmbH
Industriegebiet Saal
Donaustraße 24
93342 Saal/Donau
Germany

Phone: +49 (0) 9441 6860 0
Fax: +49 (0) 9441 6860 30
E-mail: info@syntacoll.de

Our Locations


Innocoll is a global company operating in Europe and the US, with plans to further partner in other high-potential areas around the world. Innocoll Inc. and SyntaColl GmbH are wholly owned subsidiaries of Innocoll Pharmaceuticals.

USA

Innocoll Inc.

3803 West Chester Pike
Newtown Square, PA 19073
United States
Phone: +1 (484) 406-5200
E-mail: info@innocoll.com

IRELAND

Innocoll Pharmaceuticals

Unit 9, Block D
Monksland Business Park
Monksland
Athlone
Co. Roscommon
Ireland
Phone: +353 (0) 90 6486834
Fax: +353 (0) 90 6486835
E-mail: info@innocoll.com

GERMANY

Syntacoll GmbH

Industriegebiet Saal
Donaustraße 24
93342 Saal/Donau
Germany
Phone: +49 (0) 9441 6860 0
Fax: +49 (0) 9441 6860 30
E-mail: info@syntacoll.de

COLLAGUARD® is a registered trademark of Innocoll Pharmaceuticals Ltd.

COLLATAMP® G is a registered trademark of EUSA/Jazz Pharmaceuticals.

SEPTOCOLL® E is a registered trademark of Biomet Deutschland GmbH.

REGENEPRO® is a registered trademark of Biomet 3i.

COLLACARE® is a registered trademark of Innocoll Pharmaceuticals Ltd.

COLLEXA® is a registered trademark of Innocoll Pharmaceuticals Ltd.

ZORPREVA® is a registered trademark of Innocoll Pharmaceuticals Ltd.

COLLARX® is a registered trademark of Innocoll Pharmaceuticals Ltd.

COLLAFILM® is a registered trademark of Innocoll Pharmaceuticals Ltd.